-
Je něco špatně v tomto záznamu ?
Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis
J. Panek, E. Koziolova, P. Stepanek, T. Etrych, O. Janouskova
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 1991
Free Medical Journals
od 1998
ProQuest Central
od 2005-01-01
Medline Complete (EBSCOhost)
od 2006-01-01
Nursing & Allied Health Database (ProQuest)
od 2005-01-01
Health & Medicine (ProQuest)
od 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
od 1998
- MeSH
- doxorubicin analogy a deriváty farmakokinetika MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nanočástice MeSH
- nosiče léků * MeSH
- optické zobrazování metody MeSH
- polymery MeSH
- protinádorové látky farmakokinetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Nanocarriers bearing anticancer drugs are promising candidates to improve the efficacy of cancer therapy and minimize side effects. The most potent cytostatics used in the treatment of various cancers are anthracyclines, e.g. doxorubicin or pirarubicin. Recently, polymer therapeutics carrying anthracyclines have been intensively studied. The precise characterization of in vitro nanocarrier biological behavior brings a better understanding of the nanocarrier characteristics and enables prediction of the behavior of the nanocarrier during in vivo application. Advanced fluorescence detection methods, e.g. fluorescence lifetime imaging microscopy (FLIM), were successfully exploited to describe the properties of various polymeric nano-systems and contributed to a complex view of anthracyclines' intracellular transport and DNA intercalation. Here, we report the application of a specific technique for processing FLIM images, called fluorescence pattern decomposition, to evaluate early events after doxorubicin or pirarubicin treatment of cells. Moreover, we characterized changes in the intracellular localization and release of the anthracyclines during the incubation of cells with polymer nanotherapeutics based on poly[N-(2-hydroxypropyl)-methacrylamide] (pHPMA).
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17020999
- 003
- CZ-PrNML
- 005
- 20190814100910.0
- 007
- ta
- 008
- 170623s2016 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.33549/physiolres.933423 $2 doi
- 035 __
- $a (PubMed)27762587
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Pánek, Jan, $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic $d 1955- $7 ola2003197902
- 245 10
- $a Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis / $c J. Panek, E. Koziolova, P. Stepanek, T. Etrych, O. Janouskova
- 520 9_
- $a Nanocarriers bearing anticancer drugs are promising candidates to improve the efficacy of cancer therapy and minimize side effects. The most potent cytostatics used in the treatment of various cancers are anthracyclines, e.g. doxorubicin or pirarubicin. Recently, polymer therapeutics carrying anthracyclines have been intensively studied. The precise characterization of in vitro nanocarrier biological behavior brings a better understanding of the nanocarrier characteristics and enables prediction of the behavior of the nanocarrier during in vivo application. Advanced fluorescence detection methods, e.g. fluorescence lifetime imaging microscopy (FLIM), were successfully exploited to describe the properties of various polymeric nano-systems and contributed to a complex view of anthracyclines' intracellular transport and DNA intercalation. Here, we report the application of a specific technique for processing FLIM images, called fluorescence pattern decomposition, to evaluate early events after doxorubicin or pirarubicin treatment of cells. Moreover, we characterized changes in the intracellular localization and release of the anthracyclines during the incubation of cells with polymer nanotherapeutics based on poly[N-(2-hydroxypropyl)-methacrylamide] (pHPMA).
- 650 _2
- $a protinádorové látky $x farmakokinetika $7 D000970
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a doxorubicin $x analogy a deriváty $x farmakokinetika $7 D004317
- 650 12
- $a nosiče léků $7 D004337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a nanočástice $7 D053758
- 650 _2
- $a optické zobrazování $x metody $7 D061848
- 650 _2
- $a polymery $7 D011108
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Koziolová, Eva $7 _AN081673 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Štěpánek, Petr, $d 1952- $7 xx0027070 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Etrych, Tomáš $7 xx0068504 $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 700 1_
- $a Janouskova, O. $u Institute of Macromolecular Chemistry of the Czech Academy of Sciences, Prague, Czech Republic
- 773 0_
- $w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 65, Suppl. 2 (2016), s. S217-S224
- 773 0_
- $t Recent achievements from Otto Wichterle Innovation Centre of Polymeric Materials and Biocev Research Projects $x 1802-9973 $g Roč. 65, Suppl. 2 (2016), s. S217-S224 $w MED00196542
- 856 41
- $u http://www.biomed.cas.cz/physiolres/ $y domovská stránka časopisu
- 910 __
- $a ABA008 $b A 4120 $c 266 $y 4 $z 0
- 990 __
- $a 20170623 $b ABA008
- 991 __
- $a 20190814101137 $b ABA008
- 999 __
- $a ok $b bmc $g 1236295 $s 981872
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 65 $c Suppl. 2 $d S217-S224 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
- BMC __
- $a 2016 $b 65 $c Suppl. 2 $d S217-S224 $i 1802-9973 $m Recent achievements from Otto Wichterle Innovation Centre of Polymeric Materials and Biocev Research Projects $x MED00196542
- LZP __
- $b NLK118 $a Pubmed-20170623